Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes [NA]
Clinical trial evaluating intensive diabetes clinic and continuous glucose monitors in teenagers with Type 1 diabetes completed with posted …
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Incretin-based Therapy in Early Diagnosed Type 1 Diabetes [Phase 2]
Phase 2 clinical trial evaluating incretin-based therapy in early-diagnosed Type 1 Diabetes has completed.
-
FDA approval · 2021-12-17FDA Approved: REZVOGLAR KWIKPEN — Original Application (Eli Lilly and Company)
The FDA approved Rezvoglar KwikPen (insulin glargine-AGLR) from Eli Lilly as an original application, providing a long-acting insulin option…
-
CLINICAL_TRIALS trial_result · 2021-12-06Clinical Trial Update: Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study) [Phase 4]
Phase 4 trial assessing the impact of insulin analogues on oxidative stress in people with Type 1 Diabetes.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients [Phase 3]
A Phase 3 trial comparing Tropicamide 0.5% versus Tropicamide 1% on intraocular pressure in patients with diabetes has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-11-19Clinical Trial Update: Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021 [Phase 4]
Phase 4 trial update on efficacy and safety of a recombinant human insulin patch.
-
CLINICAL_TRIALS trial_result · 2021-11-18Clinical Trial Update: Autologous Hematopoietic Stem Cell Transplantation for Early Onset Type 1 Diabetes [Phase 2]
Phase 2 trial update on autologous hematopoietic stem cell transplantation for early-onset Type 1 Diabetes; study completed.
-
CLINICAL_TRIALS trial_result · 2021-11-11Clinical Trial Update: Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp [NA]
Feasibility study results for a Zone-MPC controller with HMS and Technosphere Insulin inhalation system in Type 1 Diabetes Mellitus have bee…
-
FDA approval · 2021-10-22FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for NovoLog (insulin aspart) from Novo Nordisk. The action updates/expands the drug's approved l…
-
CLINICAL_TRIALS trial_result · 2021-09-30Clinical Trial Update: A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus [Phase 4]
Phase 4 trial in children and adolescents with newly diagnosed Type 1 diabetes assessing rapid-acting mealtime insulin.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation [Phase 2]
Phase 2 trial evaluating safety and effectiveness of low molecular weight sulfated dextran in islet transplantation for type 1 diabetes. Com…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Insulin Pump to Multiple Daily Injection Transition Clinical Trial [Phase 4]
Phase 4 clinical trial evaluating transition from insulin pump therapy to multiple daily injections in Type 1 Diabetes has completed with re…
-
CLINICAL_TRIALS trial_result · 2021-09-13Clinical Trial Update: Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 Diabetes [Phase 2]
Phase 2 trial evaluating bromocriptine quick release as an adjunct therapy in type 1 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Evaluation of Coffee Therapy for Improvement of Renal Oxygenation [Phase 2]
Phase 2 clinical trial evaluating coffee therapy to improve renal oxygenation; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-08-31Clinical Trial Update: Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating copeptin in adolescent participants with type 1 diabetes and early renal hemodynamic changes has compl…
-
CLINICAL_TRIALS trial_result · 2021-08-25Clinical Trial Update: A Study of LY900014 Versus Insulin Lispro (Humalog) on High Blood Sugar in Participants With Type 1 Diabetes Who Use Insulin Pumps [Phase 1]
Phase 1 trial comparing LY900014 to insulin lispro (Humalog) in type 1 diabetes patients using insulin pumps has completed with results post…
-
CLINICAL_TRIALS trial_result · 2021-08-23Clinical Trial Update: European Trial of Immunosuppression in SPK Tx [Phase 3]
Phase 3 trial update of immunosuppression in simultaneous kidney-pancreas transplantation has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Evaluation of Fiasp® (Fast Acting Insulin Aspart) in 670G Hybrid Closed-Loop Therapy [Phase 4]
Phase 4 clinical trial evaluating Fiasp (fast-acting insulin aspart) in 670G hybrid closed-loop therapy for type 1 diabetes; study completed…
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Tocilizumab (TCZ) in New-onset Type 1 Diabetes [Phase 2]
Phase 2 trial evaluating tocilizumab for new-onset type 1 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes [NA]
A completed clinical trial evaluating initiation of continuous glucose monitoring at diagnosis in individuals with Type 1 Diabetes Mellitus.
-
CLINICAL_TRIALS research · 2021-08-16Clinical Trial Update: Participant-Reported Outcomes With the Accu-Chek® Solo Micropump System [NA]
A completed clinical trial evaluating patient-reported outcomes for the Accu-Chek Solo micropump in type 1 diabetes.
-
FDA approval · 2021-08-13FDA Approved: LYUMJEV — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for LYUMJEV (insulin lispro-aabc) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2021-08-04Clinical Trial Update: New Onset Type 1 Diabetes: Role of Exenatide [Phase 4]
Phase 4 trial update exploring the role of exenatide in new-onset Type 1 diabetes has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-30Clinical Trial Update: TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk [NA]
A completed primary prevention trial (TRIGR) evaluating type 1 diabetes prevention in at-risk children; results posted in 2021.
-
FDA approval · 2021-07-28FDA Approved: INSULIN GLARGINE — Original Application (Biocon Biologics Inc.)
FDA approved Biocon Biologics Inc.'s insulin glargine biosimilar under an Original Application, expanding access to insulin glargine therapy…